Hypokalemia in chronic migraine with medication overuse headache: a retrospective cross-sectional study
Abstract
BACKGROUND: Potassium may be involved in the pathogenesis of migraine. Patients with chronic migraine and medication-overuse headache (CM-MOH) appear to be at a high risk for hypokalemia. METHODS: A retrospective cross-sectional study enrolled 139 consecutive patients with CM-MOH and 139 age- and sex-matched patients with healthy controls from our center. The demographic and clinical characteristics of the patients were recorded upon admission. The following morning, blood tests for potassium and magnesium concentrations were performed. RESULTS: The mean age of patients in the two groups was 48.60 ± 11.81 (CM-MOH) vs. 48.69 ± 11.99 (control). Migraineurs had a significantly lower serum potassium level (3.76 ± 0.35 mmol/L vs. 4.03 ± 0.30 mmol/L p < 0.001) and a higher prevalence of hypokalemia (21.6% versus 2.2% p < 0.001) compared to controls. A positive association between potassium and magnesium levels was observed in patients with CM-MOH (r = 0.25, p = 0.004). A slightly higher level of Mg (0.90 ± 0.06mmol/L versus 0.89 ± 0.05mmol/L, p = 0.012) was detected in the CM-MOH group compared to controls. According to logistic regression models, BMI was associated with the presence of hypokalemia in patients with CM-MOH. CONCLUSION: The incidence of hypokalemia in the control group was similar to that in the general population. An increased incidence of hypokalemia and lower serum potassium levels were observed in patients with CM-MOH. It is important to monitor the serum…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 139 participants or records.
Read the paper
Related studies
- Bioactive Molecules Released in Food by Lactic Acid Bacteria: Encrypted Peptides and Biogenic Amines
- A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications
- Bioaccessibility and bioavailability of phenolic compounds
- The Glutamate Hypothesis in ALS: Pathophysiology and Drug Development
- Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery
- Effects of the Mediterranean Diet on the Components of Metabolic Syndrome Concerning the Cardiometabolic Risk
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.